Megan L. Martin
South Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.
Journal: The Lancet. Respiratory medicine
Published: October 16, 2024
The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic Control.
Journal: Microbiology spectrum
Published: June 22, 2023
Assessment of Long-Term Macrolide Exposure on the Oropharyngeal Microbiome and Macrolide Resistance in Healthy Adults and Consequences for Onward Transmission of Resistance.
Journal: Antimicrobial agents and chemotherapy
Published: March 16, 2022
Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma.
Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma.
Journal: American journal of respiratory and critical care medicine
Published: December 03, 2021
A unified call to action from Australian nursing and midwifery leaders: ensuring that Black lives matter.
Journal: Contemporary nurse
Published: August 18, 2020
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis.
Journal: American journal of respiratory and critical care medicine
Published: November 26, 2019
Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
Journal: The Lancet. Respiratory medicine
Published: February 08, 2019
PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.
Journal: PloS one
Published: April 19, 2018
Corrections. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Journal: The Lancet. Respiratory medicine
Published: April 20, 2015
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Journal: The Lancet. Respiratory medicine
Published: December 03, 2014
Last Updated: 09/26/2026